Cantor Fitzgerald lowered the firm’s price target on Nano-X Imaging (NNOX) to $11 from $14 and keeps an Overweight rating on the shares following the Q3 results. Nano-X reported revenue of $3M, below consensus estimates, driven by the company’s teleradiology services, which increased 18% year over year to $2.6M, while AI solutions increased 184% y/y to $0.4M, the analyst tells investors in a research note. U.S. deployments are ramping, and Cantor sees the potential for an expanded indication for general scans that would materially increase the company’s market opportunity and a next-gen device in development.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNOX:
- Nano-X Imaging price target lowered to $11 from $12 at Alliance Global Partners
- Nano-X Imaging Ltd. Reports Q3 2024 Financial Progress
- Nano-X Imaging Reports Revenue Growth and Strategic Expansion
- Nano-X Imaging reports Q3 EPS (23c) vs (37c) last year
- Options Volatility and Implied Earnings Moves Today, November 21, 2024